Literature DB >> 22073049

Therapy of hearing disorders - conservative procedures.

Stefan Plontke1.   

Abstract

A wide range of therapeutic strategies are available for the therapy of hearing disorders including pharmaceutical, acoustic, electrical, surgical, radiological, cognitive-behavioural and so-called "alternative" strategies. This review focuses on general conservative strategies and specific therapeutic approaches mainly for inner ear disorders, whereas surgical and device-based therapies including hearing aids and cochlear implants are described in other chapters in this volume.In addition to the systemic medication-based therapies for the treatment of hearing disorders, the rapidly growing field of local drug delivery to the inner ear as a promising therapeutic strategy is discussed on the background of unresolved issues. After description of non-drug-based therapeutic procedures, the conservative therapy of specific diseases and syndromes is reviewed.In general, there is a major discrepancy between promising animal studies up to regeneration and stem-cell transplantation, and uncontrolled experimental studies in humans on the one hand and the shortage of randomized controlled clinical trials with a high level of evidence on the other hand. Therefore, the review and comments on published clinical studies should assist the reader in making his/her own decision about the effectiveness of various, especially pharmaceutical treatments. From a critical analysis - particularly of the clinical studies presented - conclusions are drawn for the therapy of hearing disorders in the future.

Entities:  

Year:  2005        PMID: 22073049      PMCID: PMC3200997     

Source DB:  PubMed          Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg        ISSN: 1865-1011


  290 in total

Review 1.  Auditory cortical plasticity: a comparison with other sensory systems.

Authors:  J P Rauschecker
Journal:  Trends Neurosci       Date:  1999-02       Impact factor: 13.837

2.  Direct measurement of longitudinal endolymph flow rate in the guinea pig cochlea.

Authors:  A N Salt; R Thalmann; D C Marcus; B A Bohne
Journal:  Hear Res       Date:  1986       Impact factor: 3.208

3.  Ultrastructural evidence for hair cell regeneration in the mammalian inner ear.

Authors:  A Forge; L Li; J T Corwin; G Nevill
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

4.  Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.

Authors:  Haralampos Gouveris; Oksana Selivanova; Wolf Mann
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-04-29       Impact factor: 2.503

Review 5.  Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment.

Authors:  A Hróbjartsson; P C Gøtzsche
Journal:  J Intern Med       Date:  2004-08       Impact factor: 8.989

6.  Autoimmune sensorineural hearing loss.

Authors:  B F McCabe
Journal:  Ann Otol Rhinol Laryngol       Date:  1979 Sep-Oct       Impact factor: 1.547

Review 7.  Placebo interventions for all clinical conditions.

Authors:  A Hróbjartsson; P C Gøtzsche
Journal:  Cochrane Database Syst Rev       Date:  2004

8.  Regenerative proliferation in inner ear sensory epithelia from adult guinea pigs and humans.

Authors:  M E Warchol; P R Lambert; B J Goldstein; A Forge; J T Corwin
Journal:  Science       Date:  1993-03-12       Impact factor: 47.728

9.  A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss.

Authors:  J Wang; T R Van De Water; C Bonny; F de Ribaupierre; J L Puel; A Zine
Journal:  J Neurosci       Date:  2003-09-17       Impact factor: 6.167

10.  Treatment of corticosteroid-responsive autoimmune inner ear disease with methotrexate: a randomized controlled trial.

Authors:  Jeffrey P Harris; Michael H Weisman; Jennifer M Derebery; Mark A Espeland; Bruce J Gantz; A Julianna Gulya; Paul E Hammerschlag; Maureen Hannley; Gordon B Hughes; Richard Moscicki; Ralph A Nelson; John K Niparko; Steven D Rauch; Steven A Telian; Patrick E Brookhouser
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

View more
  2 in total

1.  Efficacy and safety of systemic, high-dose glucocorticoid therapy for idiopathic sudden sensorineural hearing loss : Study protocol for a three-armed, randomized, triple-blind, multicenter trial (HODOKORT).

Authors:  Stefan K Plontke; Matthias Girndt; Christoph Meisner; Iris Böselt; Beatrice Ludwig-Kraus; Michael Richter; Torsten Rahne
Journal:  HNO       Date:  2022-06-20       Impact factor: 1.330

Review 2.  Diagnostics and therapy of sudden hearing loss.

Authors:  Stefan K Plontke
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2018-02-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.